Recombinant FKBP3 protein (His tag)

Recombinant FKBP3 protein (His tag)

Cat.#: 542529

Size:

Special Price 294.7 USD

Availability: 3-4 weeks
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Recombinant FKBP3 protein (His tag)
  • Documents
  • Description

    Recombinant Human Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) fragment (amino acids 110-224) is a high-purity protein designed for studying the FKBP-type PPIase domain. This fragment fully encompasses the functional domain (residues 128-224), making it an ideal tool for investigating isomerase activity and immunophilin-related mechanisms in a targeted manner.

    Peptidyl-prolyl cis-trans isomerase FKBP3 is a member of the FK506-binding protein (FKBP) family, which functions as receptors for immunosuppressants like FK506 and rapamycin. These proteins play critical roles in inhibiting T-cell proliferation by disrupting distinct cytoplasmic signaling pathways. As a PPIase, FKBP3 accelerates protein folding by catalyzing the cis-trans isomerization of proline imidic peptide bonds. The full-length protein is localized to the nucleus, indicating its potential involvement in nuclear processes. The recombinant fragment provided focuses specifically on the FKBP-type PPIase domain, enabling precise research into its isomerase functions and interactions without interference from other protein regions.

  • Protein name
    Peptidyl-prolyl cis-trans isomerase FKBP3
  • Uniprot ID
    Q00688
  • Gene Name
    FKBP3; FKBP25
  • Source/Expression Host
    E. coli
  • Expression Plasmid/cDNA
    DNA encoding 110-224 aa (Q00688) were fused with 6His tag.
  • Protein Species
    Human
  • Molecular weight
    Predictes a molecular mass of 14.49 kDa. In SDS-PAGE under reducing conditions, it migrates as an approximately 15 kDa band.
  • Purity
    >90%, by SDS-PAGE with Coomassie Brilliant Blue staining.
  • Activity
    Not tested.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"